| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002326549 |
| P356 | DOI | 10.1038/NRI3818 |
| P932 | PMC publication ID | 6314495 |
| P698 | PubMed publication ID | 25720354 |
| P2093 | author name string | Kazuyuki Furuta | |
| Paul A Roche | |||
| P2860 | cites work | A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation | Q24298726 |
| Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins | Q24304937 | ||
| Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes | Q24317219 | ||
| MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation | Q24318499 | ||
| Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization | Q24561527 | ||
| The induction of tolerance by dendritic cells that have captured apoptotic cells | Q24671078 | ||
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| MHC class II association with lipid rafts on the antigen presenting cell surface | Q27008954 | ||
| Inhibition of MHC class II expression and immune responses by c-MIR | Q28247142 | ||
| Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression | Q28273723 | ||
| ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells | Q28506676 | ||
| Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation | Q28585845 | ||
| Novel regulation of MHC class II function in B cells | Q28586416 | ||
| Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression | Q28589598 | ||
| Phagosomes are competent organelles for antigen cross-presentation | Q28591811 | ||
| Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance | Q28593303 | ||
| Cathepsin S required for normal MHC class II peptide loading and germinal center development | Q28611850 | ||
| Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages | Q29547420 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
| Syk-dependent actin dynamics regulate endocytic trafficking and processing of antigens internalized through the B-cell receptor | Q30479947 | ||
| Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain. | Q39966059 | ||
| Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination | Q40194881 | ||
| Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation | Q40332851 | ||
| AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. | Q40450171 | ||
| Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. | Q40478188 | ||
| Endogenous MHC class II processing of a viral nuclear antigen after autophagy. | Q40481959 | ||
| MHC class II molecules traffic into lipid rafts during intracellular transport | Q40512665 | ||
| Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. | Q40653773 | ||
| Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis | Q40691199 | ||
| Mature dendritic cells use endocytic receptors to capture and present antigens | Q30493720 | ||
| Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. | Q30559146 | ||
| TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation | Q30596786 | ||
| Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes | Q30778649 | ||
| Pathways of antigen processing | Q33631854 | ||
| Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase | Q33763110 | ||
| Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments | Q33833534 | ||
| A coat protein on phagosomes involved in the intracellular survival of mycobacteria | Q33862936 | ||
| Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex | Q33932719 | ||
| Viral subversion of the immune system | Q33932763 | ||
| Cell biology of antigen processing in vitro and in vivo | Q33985828 | ||
| Dendritic cells continue to capture and present antigens after maturation in vivo | Q34084191 | ||
| Early events in B cell activation | Q34101385 | ||
| Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. | Q34116845 | ||
| Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes | Q34158527 | ||
| Francisella tularensis elicits IL-10 via a PGE₂-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation | Q34277992 | ||
| Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation | Q34349848 | ||
| In vivo requirement for Atg5 in antigen presentation by dendritic cells | Q34376166 | ||
| Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells | Q34377531 | ||
| Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus | Q34438938 | ||
| CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. | Q34501441 | ||
| Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes | Q34593324 | ||
| Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). | Q35423428 | ||
| Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells | Q35627649 | ||
| Association of MHC class II-peptide complexes with plasma membrane lipid microdomains | Q35634044 | ||
| Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells | Q35832131 | ||
| Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells | Q35991964 | ||
| MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length | Q36061581 | ||
| The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. | Q36118069 | ||
| Phagocytosis: elegant complexity | Q36127867 | ||
| Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens | Q36140598 | ||
| Endocytosis and the recycling of plasma membrane | Q36206544 | ||
| Autonomous phagosomal degradation and antigen presentation in dendritic cells | Q36221894 | ||
| Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond | Q36266461 | ||
| Human resident langerhans cells display a lysosomal compartment enriched in MHC class II | Q72727651 | ||
| Transport of peptide-MHC class II complexes in developing dendritic cells | Q73698434 | ||
| Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice | Q74595052 | ||
| CIIV, MIIC and other compartments for MHC class II loading | Q77844640 | ||
| Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells | Q78516497 | ||
| The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation | Q81300353 | ||
| CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells | Q81475154 | ||
| SWAP-70 regulates RhoA/RhoB-dependent MHCII surface localization in dendritic cells | Q81995305 | ||
| Autoregulation of MARCH1 expression by dimerization and autoubiquitination | Q83906899 | ||
| Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells | Q84569562 | ||
| Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII. | Q40752702 | ||
| Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation | Q40820913 | ||
| Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface | Q40867441 | ||
| Invariant chain structure and MHC class II function | Q40968427 | ||
| Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. | Q41038581 | ||
| Developmental regulation of MHC class II transport in mouse dendritic cells. | Q41093187 | ||
| MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells | Q41339121 | ||
| Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. | Q41457392 | ||
| Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen | Q41467922 | ||
| Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding | Q41731115 | ||
| Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. | Q41929057 | ||
| Epitope-specific enhancement of antigen presentation by invariant chain | Q41937027 | ||
| Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells | Q42132231 | ||
| The lymph as a pool of self-antigens | Q42672113 | ||
| Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. | Q42811453 | ||
| TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation | Q43101212 | ||
| MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. | Q43645305 | ||
| Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. | Q43867716 | ||
| Activation of lysosomal function during dendritic cell maturation | Q44333919 | ||
| A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent | Q44791801 | ||
| Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate | Q45345585 | ||
| Exploring the MHC-peptide matrix of central tolerance in the human thymus. | Q45929502 | ||
| Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. | Q45946092 | ||
| The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells | Q46071205 | ||
| Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. | Q46299578 | ||
| Regulation of phagosome maturation by signals from toll-like receptors | Q47604798 | ||
| Developmental control of endocytosis in dendritic cells by Cdc42. | Q50119612 | ||
| Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane | Q50335826 | ||
| Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. | Q52004514 | ||
| T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. | Q54026692 | ||
| Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. | Q54569550 | ||
| MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. | Q54705034 | ||
| Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. | Q54786854 | ||
| Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance | Q56701390 | ||
| Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells | Q57134111 | ||
| Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling | Q57204114 | ||
| ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming | Q57267744 | ||
| Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
| Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells | Q58198307 | ||
| Toll-dependent selection of microbial antigens for presentation by dendritic cells | Q59063722 | ||
| Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination | Q59077373 | ||
| Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes | Q59098594 | ||
| TLR signalling and phagosome maturation: an alternative viewpoint | Q60343837 | ||
| Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells | Q62735441 | ||
| Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments | Q71843540 | ||
| Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. | Q36266484 | ||
| Right place, right time, right peptide: DO keeps DM focused | Q36266508 | ||
| Regulation of MHC class II gene expression by the class II transactivator | Q36274925 | ||
| Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors | Q36349536 | ||
| Phagocytosis of antigens by Langerhans cells in vitro | Q36362124 | ||
| The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli | Q36368355 | ||
| Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation | Q36370092 | ||
| In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination | Q36402359 | ||
| Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells | Q36436748 | ||
| T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes | Q36439289 | ||
| Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells | Q36532094 | ||
| Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. | Q36654119 | ||
| Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters | Q36832560 | ||
| MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells | Q36907903 | ||
| MHC class II molecules on the move for successful antigen presentation | Q37018661 | ||
| Pathogenic CD4⁺ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. | Q37246540 | ||
| Antigen-presentation properties of plasmacytoid dendritic cells | Q37272231 | ||
| Salmonella regulates polyubiquitination and surface expression of MHC class II antigens | Q37291725 | ||
| Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma | Q37295688 | ||
| Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation | Q37394995 | ||
| Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages | Q37410355 | ||
| Virus entry by macropinocytosis | Q37464753 | ||
| Dendritic cell-derived exosomes for cancer immunotherapy: what's next? | Q37690060 | ||
| Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis | Q37700775 | ||
| Autophagy and adaptive immunity | Q37768484 | ||
| Macropinocytosis: an endocytic pathway for internalising large gulps | Q37855532 | ||
| Ubiquitin and membrane protein turnover: from cradle to grave | Q37992157 | ||
| Cross-presentation by dendritic cells | Q38025870 | ||
| Association of major histocompatibility complex II with cholesterol- and sphingolipid-rich membranes precedes peptide loading | Q38340325 | ||
| Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens | Q39043478 | ||
| Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase | Q39221350 | ||
| Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells | Q39474621 | ||
| LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens | Q39697429 | ||
| The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway | Q39769129 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 203-216 | |
| P577 | publication date | 2015-02-27 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | The ins and outs of MHC class II-mediated antigen processing and presentation | |
| P478 | volume | 15 |
| Q64119832 | A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy |
| Q41782459 | A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule |
| Q49597523 | A major isoform of the E3 ubiquitin ligase March-I in antigen presenting cells has regulatory sequences within its gene |
| Q97528000 | A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation |
| Q99233874 | A molecular sensor to quantify the localization of proteins, DNA and nanoparticles in cells |
| Q30040724 | A time transect of exomes from a Native American population before and after European contact |
| Q90707116 | AAV D-sequence-mediated suppression of expression of a human major histocompatibility class II gene: Implications in the development of AAV vectors for modulating humoral immune response |
| Q99711232 | Allergy Modulation by N-3 Long Chain Polyunsaturated Fatty Acids and Fat Soluble Nutrients of the Mediterranean Diet |
| Q42696825 | An introduction to Deep learning on biological sequence data - Examples and solutions |
| Q36604367 | Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry |
| Q59800454 | Analysis of the Effect of Intestinal Ischemia and Reperfusion on the Rat Neutrophils Proteome |
| Q58095422 | Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules |
| Q38708254 | Angiotensin-converting enzyme affects the presentation of MHC class II antigens |
| Q40302214 | Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. |
| Q36820735 | Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance |
| Q38874605 | Antigen Processing and Presentation Mechanisms in Myeloid Cells |
| Q26774998 | Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus |
| Q42696537 | Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers |
| Q59127586 | Association of bovine major histocompatibility complex (BoLA) gene polymorphism with colostrum and milk microbiota of dairy cows during the first week of lactation |
| Q36539023 | Atopic donor status does not influence the uptake of the major grass pollen allergen, Phl p 5, by dendritic cells |
| Q99573638 | Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 |
| Q47111281 | Autoimmunity as a Driving Force of Cognitive Evolution |
| Q64960247 | Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. |
| Q47823584 | Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α+ dendritic cells. |
| Q26750999 | Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets |
| Q90055173 | BCAP Regulates Dendritic Cell Maturation Through the Dual-Regulation of NF-κB and PI3K/AKT Signaling During Infection |
| Q40671055 | Bacillus Calmette-Guérin-inoculation at different time points influences the outcome of C57BL/6 mice infected with Plasmodium chabaudi chabaudi AS. |
| Q94683614 | Bat Influenza Viruses: Making a Double Agent of MHC Class II |
| Q91987618 | Bats reveal the true power of influenza A virus adaptability |
| Q93335001 | Biological Consequences of MHC-II Expression by Tumor Cells in Cancer |
| Q49228637 | CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells. |
| Q36920830 | CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. |
| Q90370724 | Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma |
| Q35925584 | Cancer immunotherapy: exploiting neoepitopes |
| Q33765990 | Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury. |
| Q52868112 | Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata. |
| Q93020630 | Class II MHC antigen processing in immune tolerance and inflammation |
| Q39200323 | Clonal selection versus clonal cooperation: the integrated perception of immune objects |
| Q33838777 | Comparing Proteolytic Fingerprints of Antigen-Presenting Cells during Allergen Processing |
| Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
| Q86243687 | Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody |
| Q57808143 | Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome |
| Q28603015 | Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity |
| Q47144276 | Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity |
| Q91711499 | Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade |
| Q90257760 | Definition of naturally processed peptides reveals convergent presentation of autoantigenic topoisomerase-I epitopes in scleroderma |
| Q39428325 | Dendritic Cells and Their Role in Allergy: Uptake, Proteolytic Processing and Presentation of Allergens. |
| Q98195560 | Dendritic cell biology and its role in tumor immunotherapy |
| Q95628131 | Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics |
| Q57484891 | Designing of CD8 and CD8-overlapped CD4 epitope vaccine by targeting late and early proteins of human papillomavirus |
| Q56395856 | Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands |
| Q55001717 | Development of endocytosis, degradative activity, and antigen processing capacity during GM-CSF driven differentiation of murine bone marrow. |
| Q89075998 | Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection |
| Q88301302 | Dysfunction of antigen processing and presentation by dendritic cells in cancer |
| Q90361766 | ER Stress Responses: An Emerging Modulator for Innate Immunity |
| Q92332679 | Effects of perioperative transcutaneous electrical acupoint stimulation on monocytic HLA-DR expression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass: study protocol for a double-blind randomized controlled trial |
| Q38732881 | Efficient Culture of Human Naive and Memory B Cells for Use as APCs |
| Q90010975 | Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy |
| Q91496410 | Engineering dendritic cell vaccines to improve cancer immunotherapy |
| Q92267294 | Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor |
| Q55024423 | Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. |
| Q46498824 | Evolution of the immune system influences speciation rates in teleost fishes |
| Q35951395 | Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells |
| Q37089336 | Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination |
| Q39039850 | Extracellular Vesicles: Unique Intercellular Delivery Vehicles |
| Q39266287 | Factor VIII inhibitors: Advances in basic and translational science. |
| Q59337036 | Footprints of antigen processing boost MHC class II natural ligand predictions |
| Q92005460 | Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity |
| Q26770383 | Function and Dynamics of Tetraspanins during Antigen Recognition and Immunological Synapse Formation |
| Q38519794 | Functions of dendritic-cell-bound IgE in allergy |
| Q59356081 | Getting in and Staying Alive: Role for Coronin 1 in the Survival of Pathogenic Mycobacteria and Naïve T Cells |
| Q36355056 | Global survey of the immunomodulatory potential of common drugs. |
| Q47547305 | Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells |
| Q58800972 | Hedgehog Signaling Pathway and Autophagy in Cancer |
| Q92503563 | High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells |
| Q99234080 | High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation |
| Q92238669 | Human Inner Ear Immune Activity: A Super-Resolution Immunohistochemistry Study |
| Q26741035 | Human leukocyte Antigen-DM polymorphisms in autoimmune diseases |
| Q38709517 | Hurdles to the introduction of new therapies for immune-mediated kidney diseases |
| Q60301977 | Hypoxia potentiates monocyte-derived dendritic cells for release of tumor necrosis factor α via MAP3K8 |
| Q42370805 | IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils. |
| Q51556710 | Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. |
| Q60301328 | Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus |
| Q37011094 | IgE-mediated enhancement of CD4(+) T cell responses requires antigen presentation by CD8α(-) conventional dendritic cells. |
| Q46075584 | Igβ ubiquitination activates PI3K signals required for endosomal sorting. |
| Q59348948 | Immune evasion of the CD1d/NKT cell axis |
| Q38982422 | Immunogenic cell death in cancer and infectious disease |
| Q97521667 | Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction |
| Q89455203 | Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques |
| Q42371905 | In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis |
| Q39177220 | Influence of protein fold stability on immunogenicity and its implications for vaccine design |
| Q47290509 | Informatics for cancer immunotherapy |
| Q38712079 | Innate lymphoid cells and the MHC. |
| Q55444585 | Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura. |
| Q64898709 | Interferon Regulatory Factors 1 and 2 Play Different Roles in MHC II Expression Mediated by CIITA in Grass Carp, Ctenopharyngodon idella. |
| Q36283902 | Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS |
| Q42131303 | Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration |
| Q38684644 | Intracellular uptake of macromolecules by brain lymphatic endothelial cells during zebrafish embryonic development. |
| Q36990233 | Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture |
| Q42808850 | Late Endosomal Recycling of Open MHC-I Conformers. |
| Q64913924 | Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer. |
| Q50099240 | MHC Class II Activation and Interferon-γ Mediate the Inhibition of Neutrophils and Eosinophils by Staphylococcal Enterotoxin Type A (SEA). |
| Q90201609 | MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota |
| Q111946790 | MHC Class II variability in bare-nosed wombats (Vombatus ursinus) |
| Q26781316 | Macroautophagy in Endogenous Processing of Self- and Pathogen-Derived Antigens for MHC Class II Presentation |
| Q34522172 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy |
| Q55014189 | Mechanisms of Fish Macrophage Antimicrobial Immunity. |
| Q26781338 | Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications |
| Q48630939 | Modulating the immune system through nanotechnology. |
| Q64087115 | Molecular and Structural Characterization of MHC Class II β Genes Reveals High Diversity in the Cold-Adapted Icefish Chionodraco hamatus |
| Q38773238 | NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes |
| Q38822747 | Natural selection on MHC IIβ in parapatric lake and stream stickleback: Balancing, divergent, both or neither? |
| Q52597639 | PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells. |
| Q38914295 | Peptide-based synthetic vaccines. |
| Q64067191 | Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products |
| Q91048642 | Perivascular macrophages in health and disease |
| Q92762054 | Plant-derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells |
| Q38697228 | Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages |
| Q59807111 | Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential |
| Q38944118 | Preparing the lethal hit: interplay between exo- and endocytic pathways in cytotoxic T lymphocytes |
| Q47680055 | Previous Ingestion of Lactococcus lactis by Ethanol-Treated Mice Preserves Antigen Presentation Hierarchy in the Gut and Oral Tolerance Susceptibility. |
| Q47548337 | Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis. |
| Q89886586 | Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells |
| Q89495098 | Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides |
| Q92773357 | Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study |
| Q64946408 | Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. |
| Q37109535 | Rainbow trout CK9, a CCL25-like ancient chemokine that attracts and regulates B cells and macrophages, the main antigen presenting cells in fish |
| Q64118079 | Regulation of T cell expansion by antigen presentation dynamics |
| Q98951948 | Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction |
| Q58716481 | Robust Innate Immunity of Young Rabbits Mediates Resistance to Rabbit Hemorrhagic Disease Caused by Lagovirus Europaeus GI.1 But Not GI.2 |
| Q50557098 | Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin. |
| Q89813805 | SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport |
| Q38844774 | STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis. |
| Q40990114 | Salivary Tick Cystatin OmC2 Targets Lysosomal Cathepsins S and C in Human Dendritic Cells |
| Q36778316 | Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity |
| Q57271477 | Second signals rescue B cells from activation-induced mitochondrial dysfunction and death |
| Q37580778 | Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells. |
| Q98465703 | Specificity of the T Cell Response to Protein Biopharmaceuticals |
| Q48974238 | Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds |
| Q91941856 | Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against re |
| Q26746162 | Targeting dendritic cells: a promising strategy to improve vaccine effectiveness |
| Q54958028 | Tetraspanins as Organizers of Antigen-Presenting Cell Function. |
| Q64118744 | The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice |
| Q64248056 | The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells |
| Q39104926 | The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules |
| Q61803776 | The Human Endolymphatic Sac and Inner Ear Immunity: Macrophage Interaction and Molecular Expression |
| Q39711277 | The Human Thymus Is Enriched for Autoreactive B Cells. |
| Q40084597 | The MARCH family joins the antigen cross-presentation party. |
| Q39225428 | The Other Function: Class II-Restricted Antigen Presentation by B Cells |
| Q60944020 | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
| Q37407879 | The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation. |
| Q96128013 | The dormant cancer cell life cycle |
| Q39084138 | The elucidation of non-classical MHC class II antigen processing through the study of viral antigens |
| Q57165421 | The immunobiology of ubiquitin-dependent B cell receptor functions |
| Q94672281 | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? |
| Q40975860 | The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer |
| Q99551841 | Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers |
| Q64917249 | Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis. |
| Q54267458 | Toll-like receptor 9 antagonizes antibody affinity maturation. |
| Q64880876 | Transcriptome Analysis Shows That IFN-I Treatment and Concurrent SAV3 Infection Enriches MHC-I Antigen Processing and Presentation Pathways in Atlantic Salmon-Derived Macrophage/Dendritic Cells. |
| Q37648708 | Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice |
| Q38743924 | Tregs restrain dendritic cell autophagy to ameliorate autoimmunity. |
| Q36973311 | Tropism of CPMV to Professional Antigen Presenting Cells Enables a Platform to Eliminate Chronic Infections |
| Q90729744 | Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer |
| Q35990017 | Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells |
| Q27691330 | Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model |
| Q36088877 | Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine |
| Q92542822 | Unraveling the Molecular Signature of Extracellular Vesicles From Endometrial-Derived Mesenchymal Stem Cells: Potential Modulatory Effects and Therapeutic Applications |
| Q36980842 | Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats. |
| Q52884764 | [Autophagy, autoimmunity and autoimmune diseases]. |
| Q38951050 | mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function |
| Q37244315 | miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells |
| Q58714695 | α-Gal on the protein surface affects uptake and degradation in immature monocyte derived dendritic cells |
| Q47406087 | β2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4+ T cells |
| Q36799661 | β2-adrenoceptor signaling reduction in dendritic cells is involved in the inflammatory response in adjuvant-induced arthritic rats |
Search more.